Microparticles and Nanoparticles Delivered in Intravenous Saline and in an Intravenous Solution of a Therapeutic Antibody Product.

about

Microparticles and Nanoparticles Delivered in Intravenous Saline and in an Intravenous Solution of a Therapeutic Antibody Product.

Item

http://www.wikidata.org/entity/Q48036411

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Microparticles and Nanoparticl ...... Therapeutic Antibody Product.

@en

Microparticles and Nanoparticl ...... Therapeutic Antibody Product.

@nl

type

Item

label

Microparticles and Nanoparticl ...... Therapeutic Antibody Product.

@en

Microparticles and Nanoparticl ...... Therapeutic Antibody Product.

@nl

prefLabel

Microparticles and Nanoparticl ...... Therapeutic Antibody Product.

@en

Microparticles and Nanoparticl ...... Therapeutic Antibody Product.

@nl

P1476

Microparticles and Nanoparticl ...... Therapeutic Antibody Product.

@en

P2093

John F Carpenter

http://www.w3.org/2001/XMLSchema#string

Kevin Dahl

http://www.w3.org/2001/XMLSchema#string

Liron Caplan

http://www.w3.org/2001/XMLSchema#string

Neha N Pardeshi

http://www.w3.org/2001/XMLSchema#string

Wei Qi

http://www.w3.org/2001/XMLSchema#string

P2860

Aggregation of human recombinant monoclonal antibodies influences the capacity of dendritic cells to stimulate adaptive T-cell responses in vitro

Management and preparedness for infusion and hypersensitivity reactions.

Recombinant murine growth hormone particles are more immunogenic with intravenous than subcutaneous administration

Antibody-mediated side effects of recombinant proteins.

Highly aggregated antibody therapeutics can enhance the in vitro innate and late-stage T-cell immune responses

Native-like aggregates of factor VIII are immunogenic in von Willebrand factor deficient and hemophilia a mice

An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics.

Particle contamination of parenteralia and in-line filtration of proteinaceous drugs.

Stability of infliximab in polyvinyl chloride bags.

Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration.

P304

511-520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.XPHS.2016.09.028

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27832839

http://www.w3.org/2001/XMLSchema#string

P932

5237601

http://www.w3.org/2001/XMLSchema#string